📌 Key Takeaways
- Topic: Matting Agent Supplier: How to Choose the Right Silica Matting Agent Partner
- Keywords: Syloid silica
- Published: 2026-11-20 07:50:20
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Quartz? Crystalline Silica Properties, Grades and Industrial Applications
- What Is Silica? Definition, Main Types, Key Properties and Industrial Uses (2026 Guide)
- Silica for Electronic Encapsulation: Purity, CTE and Particle Size Requirements
- Younis, M. R. et al. Inorganic nanomaterials with intrinsic singlet oxygen generation for photodynamic therapy. Adv. Sci. 8, 2102587 (2021). Piece CAS Google Scholar
- Colloidal Silicon Dioxide Excipient: Uses as a Glidant and Pharmacopeia Standards
- Zhang, Q., Li, X., Peng, L., Zou, X. & Zhao, Y. Porous silica nanoparticles capped with polyethylenimine/green carbon dots for pH/redox responsive drug release. Inorg. Chem. Commun. 123, 108340 (2021). Article CAS Google Scholar
- Aerosil 200: Specifications, Applications and Equivalent Fumed Silica Grades
- Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61
Silicon Dioxide Manufacturer: Production Methods, Quality Standards and Selection Tips
What is silica (SiO₂)?
silicosis
What is the difference between fumed silica and precipitated silica?
fused silica powder The common thermal therapy tactics include PTT and magnetothermal therapy (MTT). The integration of some certain functional factors into the MSNs can induce photothermal or magnetothermal influences by external light irradiation or by applying a magnetic field, respectively. During the thermal therapy, the locally generated thermal impact can cause irreversible damage to cells or tissues at the lesion, hence attaining targeted, non-invasive treatment. Regarding PTT, organic photothermal agents (PTAs) such as phthalocyanines and porphyrins can convert light energy into heat energy through non-radiative forms of decay-vibrational relaxation, 387, 388 as well as inorganic PTAs such as noble metals achieve photothermal conversion through LSPR effect, 389, 390 to produce the temperature needed for treatment. The single MSNs-based PTT modality has been thoroughly studied, and the current research focuses on the construction of integrated nanoplatform for diagnosis and treatment, or the development of multimodal synergistic treatment strategies. 391 A recent study reported by Kadria-Vili et al. demonstrated that MSNs could encapsulate Gd 2 O 3 NPs for dual T 1 /T 2 contrast and Au nanoshell PTA for NIR light-responsive PTT, thus giving clinicians the talent to " and treat". 392 In addition, MSNs were considered as a biocompatible and multifunctional nanoplatform for photothermal-immunotherapy against melanoma tumors, through merely integrating polydopamine PTA, ovalbumin model antigen, and ammonium bicarbonate antigen release promoter. 393 PTT suffers from insufficient penetration depth of NIR light, resulting in decreased treatment efficiency. In contrast, MTT can kill deep tumor cells by increasing the temperature to 43-48 °C, without causing significant side impacts to surrounding normal cells. 394 During the action, the magnetic NPs act as thermoseeds, exposed to an alternating magnetic field, absorbing magnetic energy and dissipating thermal energy through the magnetic relaxation influence. 395, 396 In a study reported by Yao et al., MSNs-based nanoplatform was proven to achieve synergistic therapeutic influence of PTT and MTT. They used MSNs shell to coat magnetic Fe 3 O 4, and served graphene quantum dots with photothermal conversion ability as the cap to control DOX release. After reaching the tumor acidic microenvironment and applying external light and magnetic field stimuli, DOX was released in a controlled manner and the accelerated tumor hyperthermia was attained. 397 In addition to PTT and MTT, the MSNs-mediated radiofrequency thermotherapy is also reported. Especially, the Si NPs themselves can serve as an excellent sensitizer to enhance the radiofrequency radiation effect. 398 A study by Tamarov et al. demonstrated that the radiofrequency radiation could more efficiently trigger temperature-responsive drug release than infrared light, therefore inhibiting tumor cell expansion even after one treatment. 399
What drives silica raw material prices?
low alpha silica Daneshvar, F. et al. Combined X-ray radiotherapy and laser photothermal therapy of melanoma cancer cells utilizing dual-sensitization of platinum nanoparticles. J. Photochem. Photobiol. B: Biol. 203, 111737 (2020). Post CAS Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.